Caixa Capital BioMed

Caixa Capital Risc is leading the largest operation in the biotech sector in Spain, with a €55 million financing round in Sanifit

• The financing ends with a loan capitalisation of €17 million, which brings the total of the operation to 72.2 million.
• It will speed up research into SNF472, a drug designed to treat a rare disease known as calciphylaxis.
• Two new investors are joining the company: Columbus Venture Partners and Alta Life Sciences.

| Read more |

Minoryx Therapeutics announces first patient dosed in the FRAMES phase 2 trial in Friedreich’s Ataxia

June 4, 2019- Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, today announces that the first patient has been dosed with its lead candidate, leriglitazone (MIN-102), in the phase 2 FRAMES clinical trial in Friedreich’s Ataxia.

| Read more |

QIAGEN enters into agreement to acquire STAT-Dx, a Caixa Capital Risc portfolio company

STAT-Dx, a privately-held company developing the next generation of multiplex diagnostics for one-step, fully integrated molecular analysis of common syndromes. The system was unveiled in April 2017 at the European Congress of Clinical Microbiology (ECCMID) and received a first CE-IVD marking in January 2018.

| Read more |

MedLumics, a company owned by “la Caixa” and Ysios Capital, closes a financing round of 34.4 million euros

• Medlumics has closed a round of financing round of 34,4 million euros to bring their main product into the market, AblaView, an atrial fibrillation treatment in the field of cardiac arrhythmias.
• Medlumics is a company dedicated to medical technology for the treatment of cardiac diseases, with products based on photonic energy.
• Caixa Capital Risc and Ysios Capital invested in Medlumics in 2012 to support the company in its development.
• This has been the largest round in the history of the medical technology industry in Spain, and one of the largest in Europe.

| Read more |

Caixa Capital Risc participates in BioSpain 2014

• BIOSPAIN is the largest biotech event organized in Spain and one of the largest in the world

• During the event, had participated more than 800 public and private entities coming from 36 different countries.

| Read more |